The Latest Breaking News from FDA

Perrigo Co.’s Opill received U.S. clearance as the first daily oral birth-control product available without a prescription, coming at a time when reproductive rights are increasingly under fire.

Opill becomes the first hormonal birth control pill in the United States to be approved for over-the-counter sale by the Food and Drug Administration.

From convenience stores to online, the tablet "will be an available option for millions of people in the United States," the director of the FDA's Center for Drug Evaluation and Research says.

The decision will likely expand availability of daily birth control pills, but questions around affordability still remain.

U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers

FDA assistant general secretary Amy Leversidge described the judge’s decision as a victory for ‘basic fairness and for the trade union movement’.

The Food and Drug Administration on Thursday approved Opill, making it the nation’s first over-the-counter birth control pill.

The debate over how to interpret acetaminophen science has profound implications for individuals and the public

Yes, some sunscreens contain cancer-causing chemicals — but the sun is still far more dangerous

It follows a US senator calling for the FDA to investigate the drink

With the surge in new drug formulations, the growing prominence of personalized medicine, and favorable government initiatives, the biotech industry is set for significant growth this year and beyond. Thus, it could be wise to invest in fundamentally sound biotech stocks Biogen (BIIB), Alkermes (ALKS), and Theratechnologies (THTX) this month.…